JP2002539772A5 - - Google Patents

Download PDF

Info

Publication number
JP2002539772A5
JP2002539772A5 JP2000601126A JP2000601126A JP2002539772A5 JP 2002539772 A5 JP2002539772 A5 JP 2002539772A5 JP 2000601126 A JP2000601126 A JP 2000601126A JP 2000601126 A JP2000601126 A JP 2000601126A JP 2002539772 A5 JP2002539772 A5 JP 2002539772A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000601126A
Other languages
Japanese (ja)
Other versions
JP2002539772A (ja
Filing date
Publication date
Priority claimed from US09/387,699 external-priority patent/US6221660B1/en
Application filed filed Critical
Publication of JP2002539772A publication Critical patent/JP2002539772A/ja
Publication of JP2002539772A5 publication Critical patent/JP2002539772A5/ja
Withdrawn legal-status Critical Current

Links

JP2000601126A 1999-02-22 2000-02-22 Ｓｎｏｒｆ２５受容体をコードするｄｎａ Withdrawn JP2002539772A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US25537699A 1999-02-22 1999-02-22
US09/387,699 1999-08-13
US09/255,376 1999-08-13
US09/387,699 US6221660B1 (en) 1999-02-22 1999-08-13 DNA encoding SNORF25 receptor
PCT/US2000/004413 WO2000050562A2 (en) 1999-02-22 2000-02-22 Dna encoding snorf25 receptor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009212252A Division JP2010063457A (ja) 1999-02-22 2009-09-14 Ｓｎｏｒｆ２５受容体をコードするｄｎａ

Publications (2)

Publication Number Publication Date
JP2002539772A JP2002539772A (ja) 2002-11-26
JP2002539772A5 true JP2002539772A5 (https=) 2005-12-22

Family

ID=26944658

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000601126A Withdrawn JP2002539772A (ja) 1999-02-22 2000-02-22 Ｓｎｏｒｆ２５受容体をコードするｄｎａ
JP2009212252A Withdrawn JP2010063457A (ja) 1999-02-22 2009-09-14 Ｓｎｏｒｆ２５受容体をコードするｄｎａ

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009212252A Withdrawn JP2010063457A (ja) 1999-02-22 2009-09-14 Ｓｎｏｒｆ２５受容体をコードするｄｎａ

Country Status (12)

Country Link
US (3) US6221660B1 (https=)
EP (1) EP1075493B1 (https=)
JP (2) JP2002539772A (https=)
AT (1) ATE405589T1 (https=)
AU (1) AU777247B2 (https=)
CA (1) CA2362906A1 (https=)
CY (1) CY1108503T1 (https=)
DE (1) DE60039948D1 (https=)
DK (1) DK1075493T3 (https=)
ES (1) ES2312333T3 (https=)
PT (1) PT1075493E (https=)
WO (1) WO2000050562A2 (https=)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017528A1 (en) * 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
KR20080104062A (ko) * 1998-11-20 2008-11-28 아레나 파마슈티칼스, 인크. 사람의 오르판 ｇ 단백질 커플링 수용체
US7816492B2 (en) * 1998-11-20 2010-10-19 Arena Pharmaceuticals, Inc. Human G protein-coupled receptors
USRE42190E1 (en) 1998-11-20 2011-03-01 Arena Pharmaceuticals, Inc. Method of identifying a compound for inhibiting or stimulating human G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
US20030125539A1 (en) * 1999-02-22 2003-07-03 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
EP1100896A4 (en) * 1999-05-28 2003-05-02 Synaptic Pharma Corp SNORFF33 RECEPTOR ENCODING DNA
GB9923177D0 (en) * 1999-09-30 1999-12-01 Pfizer Ltd Novel polypeptide
EP1226250A2 (en) * 1999-11-03 2002-07-31 MERCK PATENT GmbH Gpcr-kd5 polypeptides and dna sequences thereof
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
ATE348162T1 (de) * 2000-05-18 2007-01-15 Bayer Healthcare Ag Regulation eines menschlichen dopamine-ähnlichen g-protein gekoppelten rezeptor.
ES2280435T3 (es) * 2000-12-01 2007-09-16 Astellas Pharma Inc. Metodo de exploracion de remedios para la diabetes.
US20030064381A1 (en) * 2001-03-07 2003-04-03 Feder John N. Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY26, expressed highly in testis and gastrointestinal tissues
US20030045685A1 (en) * 2001-03-09 2003-03-06 Tularik Inc. Novel receptors
US7053121B2 (en) * 2001-03-19 2006-05-30 Trustees Of The University Of Pennsylvania Compositions and methods for regulating circadian rhythms
CA2517027A1 (en) 2002-02-25 2003-09-04 Vaxiion Therapeutics, Inc. Minicell compositions and methods
AU2003262042A1 (en) * 2002-09-11 2004-04-30 Yamanouchi Pharmaceutical Co., Ltd. Method of screening insulin content enhancer
US20030143590A1 (en) * 2002-11-18 2003-07-31 Shyam Ramakrishnan Regulation of human dopamine-like g protein- coupled receptor
WO2004099419A2 (en) * 2003-04-30 2004-11-18 Arena Pharmaceuticals, Inc. Methods and compositions for identifying modulators of g protein-coupled receptors
US7083933B1 (en) 2003-05-09 2006-08-01 Prosidion Limited Methods for identification of modulators of OSGPR116 activity
US7405053B2 (en) * 2003-05-20 2008-07-29 The University Court Of The University Of Glasgow Materials and methods relating to G-protein coupled receptor oligomers
US7309589B2 (en) * 2004-08-20 2007-12-18 Vironix Llc Sensitive detection of bacteria by improved nested polymerase chain reaction targeting the 16S ribosomal RNA gene and identification of bacterial species by amplicon sequencing
EP1838311A1 (en) * 2004-12-24 2007-10-03 Prosidion Limited G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes
DOP2006000008A (es) * 2005-01-10 2006-08-31 Arena Pharm Inc Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
US7306203B2 (en) * 2005-01-28 2007-12-11 Platt Robert E Post assembly and spacer for use therewith
WO2006113236A2 (en) * 2005-04-14 2006-10-26 Cornell Research Foundation, Inc. Novel chemical inhibitors of neutrophil activation through the sac-dependent pathway
WO2007003960A1 (en) * 2005-06-30 2007-01-11 Prosidion Limited Gpcr agonists
EP1910290A2 (en) 2005-06-30 2008-04-16 Prosidion Limited Gpcr agonists
PE20071221A1 (es) 2006-04-11 2007-12-14 Arena Pharm Inc Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
SG10201404220TA (en) * 2006-04-11 2014-10-30 Arena Pharm Inc Methods of using gpr119 receptor to identify compounds useful for increasing bone mass in an individual
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
GB0700122D0 (en) 2007-01-04 2007-02-14 Prosidion Ltd GPCR agonists
EA016507B1 (ru) * 2007-01-04 2012-05-30 Прозидион Лимитед Пиперидиновые агонисты gpcr
PE20081849A1 (es) * 2007-01-04 2009-01-26 Prosidion Ltd Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr
CL2008000018A1 (es) * 2007-01-04 2008-08-01 Prosidion Ltd Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
US20100048632A1 (en) * 2007-01-04 2010-02-25 Matthew Colin Thor Fyfe Piperidine GPCR Agonists
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
JP2010539152A (ja) 2007-09-10 2010-12-16 プロシディオン・リミテッド 代謝障害の治療のための化合物
RU2443699C2 (ru) * 2007-09-20 2012-02-27 Айрм Ллк Соединения и композиции в качестве модуляторов активности gpr119
GB0720389D0 (en) 2007-10-18 2008-11-12 Prosidion Ltd G-Protein Coupled Receptor Agonists
GB0720390D0 (en) 2007-10-18 2007-11-28 Prosidion Ltd G-Protein coupled receptor agonists
BRPI0909469A2 (pt) * 2008-03-31 2015-12-29 Metabolex Inc compostos de oximetileno de arila e usos dos mesmos
EP2108960A1 (en) 2008-04-07 2009-10-14 Arena Pharmaceuticals, Inc. Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY
GB0812649D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
ATE557024T1 (de) * 2008-07-10 2012-05-15 Prosidion Ltd Piperidinverbindungen als gpcr-agonisten
GB0812648D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
GB0812642D0 (en) * 2008-07-10 2008-08-20 Prosidion Ltd Compounds
US20110160222A1 (en) * 2008-11-26 2011-06-30 Metabolex, Inc. Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders
WO2010084512A1 (en) 2008-12-24 2010-07-29 Cadila Healthcare Limited Novel oxime derivatives
GB0904284D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904287D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB0904285D0 (en) 2009-03-12 2009-04-22 Prosidion Ltd Compounds for the treatment of metabolic disorders
WO2010118404A2 (en) * 2009-04-09 2010-10-14 California Institute Of Technology Methods for creating or identifying compounds that bind tumor necrosis factor alpha
CN102803255A (zh) 2009-06-18 2012-11-28 卡迪拉保健有限公司 新的gpr119激动剂
US8481731B2 (en) * 2009-06-24 2013-07-09 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical composition and methods relating thereto
EA201200046A1 (ru) * 2009-06-24 2012-08-30 Бёрингер Ингельхайм Интернациональ Гмбх Новые соединения, фармацевтическая композиция и связанные с ними способы
JP2012228180A (ja) * 2009-09-02 2012-11-22 Panasonic Corp 脂質二重膜の産生方法、化学物質を検知可能とする方法、細胞、カリウムイオンを輸送する方法、および化学物質を検知または定量する方法
JP2012228181A (ja) * 2009-09-02 2012-11-22 Panasonic Corp 脂質二重膜の産生方法、化学物質を検知可能とする方法、細胞、カリウムイオンを輸送する方法、および化学物質を検知または定量する方法
US8410127B2 (en) * 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
GB201006167D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
GB201006166D0 (en) 2010-04-14 2010-05-26 Prosidion Ltd Compounds for the treatment of metabolic disorders
TW201209054A (en) 2010-05-28 2012-03-01 Prosidion Ltd Novel compounds
CN109674753A (zh) 2010-06-23 2019-04-26 希玛贝治疗股份有限公司 固态分散体
KR101563793B1 (ko) 2010-10-08 2015-10-27 카딜라 핼쓰캐어 리미티드 신규한 ｇｐｒ 119 작용물질
AR083904A1 (es) 2010-11-18 2013-04-10 Prosidion Ltd Derivados de 1,4-pirrolidinas disustituidos y 3-il-aminas y sus usos en el tratamiento de desordenes metabolicos
GB201114389D0 (en) 2011-08-22 2011-10-05 Prosidion Ltd Novel compounds
KR101913619B1 (ko) 2011-06-09 2018-12-28 리젠 파마슈티컬스 소시에떼 아노님 Gpr-119의 조절제로서의 신규한 화합물
AU2017305392A1 (en) 2016-08-03 2019-02-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053337A (en) 1989-10-30 1991-10-01 Neurogenetic Corporation DNA encoding an α2B -adrenergic receptor
US5661024A (en) 1989-10-31 1997-08-26 Synaptic Pharmaceutical Corporation DNA encoding a human serotonic (5-HT2) receptor and uses thereof
US5155218A (en) 1990-05-08 1992-10-13 Neurogenetic Corporation Dna encoding human 5-ht1d receptors
AU672768B2 (en) 1991-12-02 1996-10-17 Lundbeck Research Usa, Inc. DNA encoding a human 5-HT-1E receptor and uses thereof
US5360735A (en) 1992-01-08 1994-11-01 Synaptic Pharmaceutical Corporation DNA encoding a human 5-HT1F receptor, vectors, and host cells
JPH08500967A (ja) 1992-06-12 1996-02-06 ガーヴァン インスティチュート オブ メディカル リサーチ ヒトＡ１，Ａ２ａおよびＡ２ｂアデノシン受容体をエンコードするＤＮＡ配列
AU677968B2 (en) 1992-09-25 1997-05-15 H. Lundbeck A/S DNA encoding human alpha 1 adrenergic receptors and uses thereof
US5472866A (en) 1992-12-24 1995-12-05 Synaptic Pharmaceutical Corporation DNA encoding 5-HT4A serotonin receptors
US5516653A (en) 1993-12-28 1996-05-14 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
US5545549A (en) 1994-02-03 1996-08-13 Synaptic Pharmaceutical Corporation DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
US5602024A (en) 1994-12-02 1997-02-11 Synaptic Pharmaceutical Corporation DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
CA2348688A1 (en) 1998-10-13 2000-04-20 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human g protein-coupled receptors
KR20080104062A (ko) 1998-11-20 2008-11-28 아레나 파마슈티칼스, 인크. 사람의 오르판 ｇ 단백질 커플링 수용체
US20030017528A1 (en) * 1998-11-20 2003-01-23 Ruoping Chen Human orphan G protein-coupled receptors
US6221660B1 (en) 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
JP2004500808A (ja) 1999-12-10 2004-01-15 インサイト・ゲノミックス・インコーポレイテッド Ｇタンパク質結合受容体

Similar Documents

Publication Publication Date Title
BE2014C019I2 (https=)
BE2010C009I2 (https=)
BE2011C041I2 (https=)
BRPI0110940B8 (https=)
JP2001134748A5 (https=)
BE2014C025I2 (https=)
JP2001127304A5 (https=)
JP2001197822A5 (https=)
BY5768C1 (https=)
BRPI0003419A (https=)
BRPI0000763B8 (https=)
CN3136262S (https=)
CN3139849S (https=)
AU2001273056A2 (https=)
AU2000280388A8 (https=)
AU2000274567A8 (https=)
AU2000271150A8 (https=)
CN3133778S (https=)
CN3133951S (https=)
CN3134731S (https=)
CN3135639S (https=)
CN3135789S (https=)
CN3135921S (https=)
AU2000266391A8 (https=)
CN3136721S (https=)